Document is current
Any future updates will be listed below
-
Authors
Secondulfo, Carmine https://orcid.org/0000-0003-2742-237X
Torre, Pietro https://orcid.org/0000-0001-8245-5305
Iacuzzo, Candida
Di Pietro, Renata Angela
Apicella, Luca https://orcid.org/0000-0002-8140-9136
Vecchione, Nicoletta
Masarone, Mario https://orcid.org/0000-0003-0550-8201
Persico, Marcello https://orcid.org/0000-0002-1399-6498
Bilancio, Giancarlo https://orcid.org/0000-0002-0845-1194
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 2 May 2025
First Online: 31 May 2025
Declarations
:
: The authors have no conflicts of interest to declare that are relevant to the content of this article.
: This study is part of the “Salerno CKD Cohort Study”, an ongoing, open-ended, observational study. It was reviewed and approved by the local institutional ethical committee (2012—n. 589), and was performed in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki), included a written informed consent, was registered in the public registry of the Italian Drug Agency (Agenzia Italiana del FArmaco, AIFA, ID n. 654) and in the public registry of the Authority for Privacy of the Italian Parliament (Garante della Privacy, n. 102400183803).
